Amyloid-beta precursor protein
(Redirected from Amyloid precursor protein)
Amyloid-beta precursor protein
The Amyloid-beta precursor protein (APP) is a transmembrane protein that plays a crucial role in the pathogenesis of Alzheimer's disease. It is encoded by the APP gene located on chromosome 21 in humans. APP is processed through two main pathways: the amyloidogenic pathway and the non-amyloidogenic pathway.
Structure
APP is a type I transmembrane protein that undergoes post-translational modifications, including glycosylation and phosphorylation. It consists of a large extracellular domain, a single transmembrane domain, and a short cytoplasmic tail. The extracellular domain contains the amyloid-beta (Aβ) region, which is cleaved to form Aβ peptides.
Function
The exact function of APP is not fully understood, but it is believed to be involved in neuronal growth, synapse formation, and repair processes in the brain. APP is processed by enzymes called secretases, which cleave it at different sites to produce various fragments. The amyloidogenic pathway leads to the formation of Aβ peptides, which can aggregate and form plaques in the brain, a hallmark of Alzheimer's disease.
Role in Alzheimer's Disease
Mutations in the APP gene or abnormalities in its processing can lead to the accumulation of Aβ peptides, which are toxic to neurons and disrupt normal brain function. This accumulation is a key event in the development of Alzheimer's disease. The Aβ peptides can aggregate to form insoluble plaques, which contribute to neurodegeneration and cognitive decline.
Clinical Significance
Research on APP and its processing pathways is essential for understanding the mechanisms underlying Alzheimer's disease and developing potential therapeutic interventions. Targeting the processing of APP to reduce the production of Aβ peptides is a promising approach for treating Alzheimer's disease.
See also
Transform your life with W8MD's budget GLP-1 injections from $125.
W8MD offers a medical weight loss program to lose weight in Philadelphia. Our physician-supervised medical weight loss provides:
- Most insurances accepted or discounted self-pay rates. We will obtain insurance prior authorizations if needed.
- Generic GLP1 weight loss injections from $125 for the starting dose.
- Also offer prescription weight loss medications including Phentermine, Qsymia, Diethylpropion, Contrave etc.
NYC weight loss doctor appointments
Start your NYC weight loss journey today at our NYC medical weight loss and Philadelphia medical weight loss clinics.
- Call 718-946-5500 to lose weight in NYC or for medical weight loss in Philadelphia 215-676-2334.
- Tags:NYC medical weight loss, Philadelphia lose weight Zepbound NYC, Budget GLP1 weight loss injections, Wegovy Philadelphia, Wegovy NYC, Philadelphia medical weight loss, Brookly weight loss and Wegovy NYC
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD